Prior studies have shown that Nr4a1 modulates macrophage and T cell-mediated inflammation as well as modulating metabolic pathways in the context of autoimmunity and oncology to constrain proinflammatory signaling and promote tolerance via transcriptional and epigenetic regulation (15–26). Here, NR4A1 is linked to Autoimmunity.